PTOISBI'DBa (03-15)
`Doc code: IDS
`Approved for use through 071312016. OMB 0651-0031
`.
`.
`.
`_
`.
`.
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Doc description. Information Disclosure Statement (IDS) FIIed
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`
`| 5789862
`
`
`I N
`
`IA
`
`Application Number
`Filing Date
`
`First Named Inventor
`
`
`
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`Art Unit
`
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number
`I AVN-OOQDVCNT
`
`
`
`
`
`
`
`
`U.S.PATENTS
`-
`
`
`Examiner Cite
`Initial*
`No
`
`Patent Number
`
`Kind
`Code1 Issue Date
`
`Name of Patentee or Applicant
`Of cited Document
`
`Pages,ColumnS,LineS where
`Relevant Passages or Relevant
`Figures Appear
`
`
`
`If you wish to add additional US. Patent citation information please click the Add button.
`Add
`U.S.PATENT APPLICATION PUBLICATIONS -
`
`
`Examiner Cite No Publication
`Initial*
`Number
`
`Publication
`Kind
`Code1 Date
`
`Name of Patentee or Applicant
`Of cited Document
`
`Pages,ColumnS,LineS where
`Relevant Passages or Relevant
`Figures Appear
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`If you wish to add additional U.S. Published Application citation information please click the Add button. Add
`FOREIGN PATENT DOCUMENTS
`-
`
`
`
`Pages,Columns,LineS
`
`Name of Patentee or
`
`where Relevant
`Kind
`Publication
`
`Examiner Cite Foreign Document
`Applicant of cited
`T5
`|nitia|*
`No
`Number3
`
`Code4 Date
`Passages or Relevant
`
`
`Document
`
`
`Figures Appear
`
`
`
`If you wish to add additional Foreign Patent Document citation information please click the Add button
`NON-PATENT LITERATURE DOCUMENTS -
`
`
`Include name of the author (in CAPITAL LETTERS), title Of the article (when appropriate), title of the item
`T5
`(book, magazine, journal, serial, symposium, catalog, etc), date, pageS(S), volume-issue number(s),
`publisher, city and/or country where published.
`
`
`EFS Web 2.1.17
`
`

`

`
`
`
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`.
`.
`( Not for submissmn under 37 CFR 1.99)
`
`Application Number 15789862
`
`Filing Date
`2017-10-20
`First Named Inventor
`Peter SAZANI
`
`Art U .
`
`mt
`I N/A
`Examiner Name
`Not Yet Assigned
`
` Attorney Docket Number
`
`
`
`
`I AVN-OOQDVCN7
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Revised Designatio
`f Lead and Backup Counsel, 4 pages, Patent Interference No. 106,007, (Doc 415), dated March 10, 2015.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Revised Designatio
`f Lead and Backup Counsel, 4 pages, Patent Interference No. 106,013, (Doc 150 ), dated March 10, 2015.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia Revised Designatio
`f Lead and Backup Counsel, 5 pages, Patent Interference No. 106,008, (Doc 423 ), dated March 10,2015.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia, Exhibit List as of
`ebruary 17, 2015, 8 pages, Patent Interference No. 106,007, (Doc No. 398) dated February 17, 2015.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, University of Western Australia, Exhibit List as of
`ebruary 17, 2015, 8 pages, Patent Interference No. 106,008, (Doc No. 406) dated February 17, 2015.
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Clean Copy of Involved Claims and
`equence, Patent Interference No. 106,007, 8 pages, dated August 1, 2014 (Doc 12)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Clean Copy of Involved Claims and
`equence, Patent Interference No. 106,013, 7 pages, dated October 14, 2014 (Doc 7)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Clean Copy of Involved Claims and
`equences, Patent Interference No. 106,008, 8 pages, dated August 7, 2014 (Doc 12)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Exhibit List as of November 18, 2014, 7
`ages, Patent Interference No. 106,008, dated November 18, 2014 (Doc 216)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Exhibit list, 7 pages, Patent Interference No.
`06,007, dated November 18,2014 (Doc 213)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Exhibit list, 7 pages, Patent Interference No.
`06,013, dated November 18,2014 (Doc 134)
`
`EFS Web 2.1.17
`
`

`

`
`
`
`15789862
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`Filing Date
`2017-10-20
`First Named Inventor
`Peter SAZANI
`
`Art Unit
`|NIA
`
` Application Number
`
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number
`
`(A)N
`
`4:.
`
`—l—l
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Exhibit List, 7 pages, Patent Interference Nos.
`06,008, dated December 12,2014 (Doc 221)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Exhibit List, 8 pages, Patent Interference No.
`06,007, dated December 12,2014 (Doc 217)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA List of Proposed Motions, Patent Interference
`0. 106,007, 7 pages, dated September 10,2014 (Doc 17)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA List of Proposed Motions, Patent Interference
`0. 106,008, 6 pages, dated September 10,2014 (Doc 16)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Miscellaneous Motion 1 (for authorization to
`lie terminal disclaimer), 5 pages, Patent Interference No. 106,008, dated October 17, 2014 (Doc 22)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Motion 1 (For Judgment Under 35 U.S_C.,
`ection 112(a)), 40 pages, Patent Interference No. 106,007, dated November 18, 2014 (Doc 210)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Motion 1 (For Judgment Under 35 § 112(a))
`'atent Interference No. 106,008 (Doc 213), 38 Pages, on November 18,2014
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Motion 1 (To Maintain Interference between
`WA US Patent No. 8,486,907 and AZL USSN 14l198,992), 45 pages, Patent Interference No. 106,013, dated
`ovember 18, 2014 (Doc 133)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Motion 2 (For Judgment Under 35 U.S_C.
`ection 112(b)), 32 pages, Patent Interference No. 106,008, dated November 18, 2014 (Doc 214)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Motion 2 (For Judgment Under 35 U.S_C.
`ection 112(b)), 34 pages, Patent Interference No. 106,007, dated November 18, 2014 (Doc 211)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Motion 3 (Forjudgment that Claims 11-12,
`4—15, and 17—29 of Application No. 131550210 are barred under 35 U_S.C. section 135(b)), 25 Pages, Patent
`nterference No. 106,008, dated November 18, 2014 (Doc 215)
`
`
`
`
`|AVN-009DVCN7
`
`—l—l"NIU'i
`
`—l
`
`|\J|\J—‘O
`
`|\JN
`
`EFS Web 2.1.17
`
`

`

`
`
`
`15789862
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`Filing Date
`2017-10-20
`First Named Inventor
`Peter SAZANI
`
`Art Unit
`|NIA
`
` Application Number
`
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Motion 3 Requesting an additional
`nterference between UWA US. Patent No. 8,455,636 and AZL USSN 147248279, 36 pages, Patent Interference No.
`06,007, dated November 18, 2014 (Doc 212)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Notice of Filing Priority Statement, 2 pages,
`'atent Interference No. 106,007, dated November 18, 2014 (Doc 215)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Notice of Filing Priority Statement, 2 pages,
`'atent Interference No. 106,008, dated November 18, 2014 (Doc 218)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Notice of Recent Authority, filed in Patent
`nterference No. 106,007, July 2, 2015, pages 1-16 (Doc 469).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Notice of Recent Authority, filed in Patent
`nterference No. 106,007, September 2, 2015, pages 1-18 (Doc 470).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Notice of Recent Authority, filed in Patent
`nterference No. 106,008, July 2, 2015, pages 1-16 (Doc 477).
`
`
`
`
`|AVN-009DVCN7
`
`|\J|\J4k00
`
`|\J0'1
`
`00|\J|\J|\J|\JO(.0CO"-40')
`
`0000N_n
`
`0000
`
`EFS Web 2.1.17
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Notice of Recent Authority, filed in Patent
`nterference No. 106,008, September 2, 2015, pages 1-18 (Doc 478).
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Notice of Related Proceedings, Patent
`nterference No. 106,007, 3 pages, dated August 1, 2014 (Doc 11)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Notice of Related Proceedings, Patent
`nterference No. 106,008, 5 pages, dated August 7, 2014 (Doc 11)
`
`niversity of Western Australia v. Academisch Ziekenhuis Leiden, UWA Notice of Related Proceedings, Patent
`nterference No. 106,013, 3 pages, dated October 14, 2014 (Doc 6)
`
`S 7,960,541 (Wilton et al.), Pages 84, Exhibit Number 1002 filed in interferences 106,007 and 106,008 on November
`8, 2014.
`
`

`

`
`
`IN FORMATION DISCLOSU RE
`
`
`First Named Inventor
`Peter SAZANI
`
`
`15789862
`
`
`Filing Date
`2017-10-20
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`Art Unit
`| MIA
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number
`
` Application Number
`
`3 8,450,474 (Wilton et at), Pages 95, Exhibit Number 1087 filed in interferences 106,007 and 106,008 on February
`3, 2015.
`
`3 8,455,634 (Wilton et al.) Pages 96, Exhibit Number 1088 filed in interferences 106,007 and 106,008 on February
`3, 2015.
`
`3 8,455,635 (Wilton et at), Pages 96, Exhibit Number 1089 filed in interferences 106,007 and 106,008 on February
`3, 2015.
`
`3 8,455,636 (Wilton et at), Pages 92, Exhibit Number 1003 filed in interferences 106,007 and 106,008 on November
`8, 2014.
`
`
`
`
`|AVN-009DVCN7
`
`00000'14:
`
`000')
`
`4:-000000O(.003"-l
`4:-4:-4:-00N—‘
`
`4:.4:.
`
`EFS Web 2.1.17
`
`3 8,476,423 (Wilton et at), Pages 95, Exhibit Number 1111 filed in interferences 106,007 and 106,008 on February
`3, 2015.
`
`3 8,501,703 (Bennett et at), Pages 16, Exhibit Number 1090 filed in interferences 106,007 and 106,008 on February
`3, 2015.
`
`3 8,501,704 (Mourich et al.), Pages 39, Exhibit Number 1091 filed in interferences 106,007 and 106,008 on
`ebruary 13, 2015.
`
`3 8,524,676 (Stein et al.), Pages 28, Exhibit Number 1092 filed in interferences 106,007 and 106,008 on February
`3, 2015.
`
`3 8,524,880 (Wilton et at), Pages 89, Exhibit Number 1093 filed in interferences 106,007 and 106,008 on February
`3, 2015.
`
`3 8,536,147 (Weller et al.), Pages 95, Exhibit Number 1094 filed in interferences 106,007 and 106,008 on February
`7, 2015.
`
`3 8,592,386 (Mourich et al.), Pages 46, Exhibit Number 1095 filed in interferences 106,007 and 106,008 on February
`3, 2015.
`
`

`

`
`
`
`
`Application Number 15789862
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`.
`.
`( Not for submissmn under 37 CFR 1.99)
`
`
`Filing Date
`2017-10-20
`First Named Inventor
`Peter SAZANI
`
`Art U .
`mt
`I N/A
`
`Examiner Name
`Not Yet Assigned
`
` Attorney Docket Number
`
`
`3, 2015.
`
`I AVN-009DVCN7
`
`3 8,618,270 (lversen et al.), Pages 28, Exhibit Number 1096 filed in interferences 106,007 and 106,008 on February
`3, 2015.
`
`3 8,637,483 (Wilton et al.), Pages 157, Exhibit Number 1097 filed in interferences 106,007 and 106,008 on February
`3, 2015.
`
`3 8,697,858 (lversen), Pages 95, Exhibit Number 1098 filed in interferences 106,007 and 106,008 on February 13,
`
`3 8,703,735 (lversen et al.) Pages 73, Exhibit Number 1099 filed in interferences 106,007 and 106,008 on February
`3, 2015.
`
`3 8,741,863 (Moulton et al.), Pages 68, Exhibit Number 1100 filed in interferences 106,007 and 106,008 on February
`3, 2015.
`
`3 8,759,307 (Stein et al.), Pages 35, Exhibit Number 1101 filed in interferences 106,007 and 106,008 on February
`
`If you wish to add additional non-patent literature document citation information please click the Add button Add
`EXAMINER SIGNATURE
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through a
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`1 See Kind Codes of USPTO Patent Documents at www.USPTO.GOV or MPEP 901.04. 2 Enter office that issued the document, by the two-letter code (WIPO
`Standard ST.3). 3 For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent document.
`4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. 5 Applicant is to place a check mark here if
`English language translation is attached.
`
`EFS Web 2.1.17
`
`

`

`
`
`Application Number 15789862
`
`Filing Date
`2017-10-20
`First Named Inventor
`Peter SAZANI
`
`Art U .
`
`mt
`I N/A
`Examiner Name
`Not Yet Assigned
`I AVN-009DVCN7
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`.
`.
`( Not for submissmn under 37 CFR 1.99)
`
`
`
` Attorney Docket Number
`
`
`
`
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s):
`
`CERTIFICATION STATEMENT
`
`That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the
`information disclosure statement. See 37 CFR 1.97(e)(1).
`
`OR
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`
`foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 1.56(c) more than three months prior to the filing of the information disclosure
`statement. See 37 CFR 1.97(e)(2).
`
`El
`
`See attached certification statement.
`
`The fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`A certification statement is not submitted herewith.
`
`SIGNATURE
`
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the
`public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the completed
`application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you
`require to complete this form andlor suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S.
`Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND
`FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria,
`VA 22313-1450.
`
`EFS Web 2.1.17
`
`
` NamelPrint
`Signature
`2017—10—30
`
`
`
`

`

`Privacy Act Statement
`
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised
`that:
`(1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited
`is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office is to
`process and/or examine your submission related to a patent application or patent.
`If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process andr'or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act
`(5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
`Department of Justice to determine whether the Freedom of Information Act requires disclosure of these record 5.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from the
`Member with respect to the subject matter of the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for
`the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant
`to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or
`his/her designee, during an inspection of records conducted by GSA as part of that agency's responsibility to
`recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904 and
`2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not be used to make
`determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record was filed in
`an application which became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`
`
`
`
`
`
`EFS Web 2.1.17
`
`